TNF-α renders human neutrophils responsive to platelet factor 4: Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines

Journal of Immunology

Volumn 156, Issue 5, 1996, Pages 1954-1962

  Petersen, Frank ^a   Ludwig, Andreas ^a   Flad, Hans Dieter ^a   Brandt, Ernst ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOCHALASIN B; INTERLEUKIN 8 RECEPTOR; RECOMBINANT INTERLEUKIN 8; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; THROMBOCYTE FACTOR 4;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DEGRANULATION; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

BIOLOGICAL MARKERS; CYTOCHALASIN B; CYTOPLASMIC GRANULES; DRUG SYNERGISM; EXOCYTOSIS; HUMANS; INTERLEUKIN-8; NEUTROPHIL ACTIVATION; PLATELET FACTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029671459     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Marcus, A J , and L B. Safier 1993. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis FASEB J. 7 516.
2. Faint, R W 1992. Platelet-neutrophil interactions: their significance. Blood 6, 83
3. Brandt, E. and H -D. Flad 1992 Structure and function of platelet-derived cytokines of the β-thromboglobulin/interleukin 8 family Platelets 3:295.
4. Niewiarowski, S , B Rucinski, and A Z. Budzynski. 1979 Low affinity platelet factor 4 and high affinity platelet factor 4: two antiheparin factors secreted by human platelets Thromb. Haemost. 42:1679.
5. Files, J. C., T W. Malpass, E. K. Yee, J. L. Ritchie, and L. A. Harker. 1981. Studies of human platelet α-release in vivo. Blood 58:607
6. Kameyoshi, Y , A Dörschner, A. I Mallet, E. Christophers, and J.-M Schroder. 1992 Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp. Med. 176:587.
7. Moore, S., D. S Pepper, and J. D Cash 1975. The isolation and characterization of platelet specific β-globulin and the detection of an anti-urokinase and anti-plasmin released from thrombin-aggregated and washed human platelets Biochim. Biophys. Acta 379:360.
8. Brandt, E . J. Van Damme, and H.-D. Flad 1991. Neutrophils can generate their activator neutrophil-activating pcptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III Cytokine 3:311.
9. Härter, L., F. Petersen, H -D Flad, and E. Brandt. 1994. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils: requirement for proteolytic formation of the neutrophil-activating peptide 2. J Immunol. 153: 5698
10. Oppenheim, J J., C. O. Zachanae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617.
11. Van Damme, J. 1991. Interleukin-8 and related molecules. In The Cytokine Handbook, A. W. Thompson, ed. Academic Press, London, p. 201.
12. Petersen, F , H.-D Flad, and E. Brandt. 1994. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same site on neutrophils but interact in different ways: discrepancies in binding affinities, receptor densities, and biologic effects. J. Immunol. 152:2467.
13. Schumacher, C., I Clark-Lewis, M. Baggiolini, and B. Moser. 1992. High- and low-affinity binding of GROα and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc. Natl. Acad. Sci. USA 89 10542.
14. Holmes, W. E., J. Lee, W. J Kuang, G C. Rice, and W. I. Wood. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253:1278.
15. Murphy, P M., and H. L. Tiffany. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280.
16. Brindley, L. L , J M. Sweet, and E. J. Goetzl. 1983. Stimulation of histamine release from human basophils by human platelet factor 4. J. Clin. Invest. 72:1218.
17. Hayashi, N., J. Chihara, Y. Kobayashi, T. Kakazu, D. Kurachi, T. Yamamoto, and S. Nakajima. 1994. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int. Arch Allergy Immunol. 104(Suppl. 1):57.
18. Han, Z C , S. Bellucci, A Walz, M. Baggiolini, and J. P. Caen. 1990 Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III). Int. J. Cell Clon. 8:253.
19. Han, Z. C., A M. Maurer, S. Bellucci, H. Y. Wan, Y. Kroviarski, O. Bertrand, and J. P. Caen. 1992 Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells proposed mechanism of action of PF4. J. Lab. Clin Med. 120:645.
20. Deuel, T F., R M Senior, D. Chang, G L Griffin, R L. Heinrikson, and E. T. Kaiser 1981. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc. Natl. Acad. Sci. USA 78.4584.
21. Senior, R. M., G. L. Griffin, J. S. Huang, D. A. Walz, and T. F. Deuel. 1983. Chemotactic activity of platelet alpha granule proteins for fibroblasts. J. Cell Biol. 96:382.
22. Castor, C. W., J. W Miller, and D A Walz 1983. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor Proc. Natl. Acad Sci. USA 80:765.
23. Leonard, E. J , T. Yoshimura, A. Rot, Noer K;, A. Walz, M. Baggiolini, D. A. Walz, E. J. Goetzl, and C. W. Castor. 1991. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor. J. Leukoc Biol 49:258.
24. Goldman, D. W., A. L Hannah, and E J. Goetzl. 1985. Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70). Immunology 54:163.
25. Bebawy, S. T., J. Gorka, T. M Hyers, and R. O. Webster. 1986. In vitro effects of platelet factor 4 on normal human neutrophil functions. J. Leukoc. Biol 39: 423.
26. Huang, S. S., J. S. Huang, and T. F. Deuel. 1982 Proteoglycan carrier of human platelet factor 4. J. Biol. Chem. 257:11546.
27. Walz, A., B. Dewald, V von Tscharner, and M. Baggiolini. 1989. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils J. Exp. Med. 170.1745
28. Clark-Lewis, I., B. Dewald, T. Geiser, B. Moser, and M. Baggiolini. 1993. Plate-let factor 4 binds to interleukin 8 receptors and activates neutrophils when its N-terminus is modified with Glu-Leu-Arg. Proc. Natl. Acad Sci. USA 90.3574.
29. Yan, Z., J Zhang, J C. Holt, G. J. Stewart, S. Niewiarowski, and M. Poncz 1994. Structural requirements of platelet chemokines for neutrophil activation. Blood 84:2329
30. Detmers, P. A , D E Powell, A Walz, I Clark-Lewis, M. Baggiolini, and Z. A. Cohn 1991. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol. 147:4211.
31. Barnett, M. L., K A. Lamb, K. M. Costello, and M. C. Pike 1993 Characterization of interleukin-8 receptors in human neutrophil membranes, regulation by guanine nucleotides. Biochim. Biophys. Acta 1177:275.
32. Clark-Lewis, I , C Schumacher, M Baggiolini, and B. Moser. 1991. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs: critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, cxocytosis, and receptor binding activities. J Biol. Chem. 266:23128.
33. Schraufstatter, I. U , D. S. Barritt, M. Ma, Z. G. Oades, and C. G. Cochrane. 1993. Multiple sites on IL-8 responsible for binding to α and β IL-8 receptors. J. Immunol. 151.6418.
34. Petersen, F., J. Van Damme, H -D. Flad, and E. Brandt. 1991. Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release Lymphokine Cytokine Res. 10:35.
35. Brandt, E , F. Petersen, and H.-D. Flad 1992. Recombinant tumor necrosis factor-α potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J. Immunol. 149:1356.
36. Brandt, E., F. Petersen, and H.-D. Flad. 1993. A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: identification by antibodies with defined epitope specificity. Mol. Immunol. 30:979.
37. Schröder, J.-M., U Mrowietz, E. Morita, and E. Christophers 1987. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J. Immunol. 139.3474.
38. Creamer, H. R., W. L. Gabler, and W. W. Bullock. 1983. Endogenous component chemotactic assay (ECCA). Inflammation 7:321.
39. 2+ indicators with greatly improved fluorescence properties. J Biol. Chem. 260: 3440.
40. Hanlon, W. A., J. Stolk, P. Davies, J. L. Humes, R. Mumford, and R. J. Bonney. 1991. rTNF alpha facilitates human polymorphonuclear leukocyte adherence to fibrinogen matrices with mobilization of specific and tertiary but not azurophilic granule markers. J. Leukoc. Biol. 50:43.
41. Berkow, R. L., D. Wang, J. W. Larrick, R. W. Dodson, and T. H. Howard. 1987. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor J Immunol 139:3783.
42. Millar, A. B., M. Singer, A. Meager, N. M. Foley, N MI Johnson, and G. A. W. Rook. 1989. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2:712.
43. Ferrante, A., M. Nandoskar, A. Walz, D. H. B. Goh, and I. C. Kowanko. 1988. Effects of tumor necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int. Arch. Allergy Immunol. 86:82.
44. Peveri, P , A. Walz, B. Dewald, and M. Baggiolini. 1988. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp. Med. 167: 1547.
45. Watanabe, M., M. Hagiwara, K. Onoda, and H. Hidaka. 1988. Monoclonal antibody recognition of two subtype forms of protein kinase C in human platelets. Biochem Biophys. Res. Commun. 152:642.
46. Brandt, E , M Ernst, H Loppnow, and H.-D. Flad. 1989. Characterization of a platelet derived factor modulating phagocyte functions and cooperating with interleukin 1. Lymphokine Res. 8:281.
47. Walz, A and M. Baggiolini. 1989. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. Biochem. Biophys Res. Commun. 159:969.
48. Levine, S. P. and L. S. Krentz. 1977. Development of a radioimmunoassay for human platelet factor 4. Thromb. Res. 11:673.
49. Singer, I. I., S. Scott, D. W. Kawka, and D. M. Kazazis. 1989. Adhesomes specific granules containing receptors for laminin, C3bi/fibrinogen, fibronectin, and vitronectin in human polymorphonuclear leukocytes and monocytes J. Cell Biol. 109:3169.
50. Thelen, M., P. Peveri, P. Kernen, V. von Tscharner, A. Walz, and M. Baggiolini. 1988. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J. 2.2702.
51. 1 changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA J. Leukoc. Biol. 50:279.
52. Richter, J , T. Andersson, and I. Olsson. 1989. Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J. Immunol 142:3199.
53. Sengelov, H., L. Kjeldsen, and N. Borregaard. 1993. Control of exocytosis in early neutrophil activation. J. Immunol. 150:1535.
54. Borregaard, N., K. Lollike, L. Kjeldsen, H. Sengelov, L. Bastholm, M H. Nielsen, and D. F. Bainton 1993. Human neutrophil granules and secretory vesicles Eur. J. Haematol. 51.187.